Part 1 - Coronary angiography with gadofosveset trisodium: A prospective feasibility study evaluating injection techniques for steady-state imaging

Mark A. Ahlman, Fabio S. Raman, Scott R. Penzak, Jianing Pang, Zhaoyang Fan, Songtao Liu, Neville Gai, Debiao Li, David A. Bluemke

Research output: Contribution to journalArticle

Abstract

Background: The purpose of this study was to define an optimal injection protocol for 5-10 min duration navigator-based coronary MR angiography using an intravascular gadolinium-based contrast agent (GBCA), which is better suited for steady-state coronary MR angiography than conventional GBCAs. Methods: Using projections from pharmacokinetic models of the intravascular concentration of gadofosveset, a dual-injection protocol was formulated and tested on 14 healthy human subjects. Modified Look-Locker inversion recovery (MOLLI) sequences were used for T1 mapping at 3 Tesla to evaluate the concentration of tracer in the aorta over the scanning interval. Results: Pharmacokinetic models for a bolus plus slow infusion technique at a 5, 10, and 15 min steady state intravascular concentration was compared to single bolus curves. The 70 %/30 % bolus/slow infusion technique resulted in the highest intravascular concentration over a 5 min scan duration. Similarly, the 60 %/40 % bolus/slow infusion technique was projected to be ideal for image acquisition duration of 5-10 min. These models were confirmed with T1 maps on normal volunteers. Arterial-venous mixing of contrast was achieved within 90 s of the beginning of the bolus. Conclusions: Gadofosveset injection is optimized for the lowest intravascular T1 time for 5-10 min duration MR angiography by bolus injection of 60-70 % of the total dose followed by slow infusion of the remainder of the total dose. This protocol achieves rapid and prolonged steady state intravascular concentrations of the GBCA that may be useful for prolonged image acquisition, such as required for navigator-based coronary MR angiography at 3 Tesla. Trial registration: ClinicalTrials.gov identifier: NCT01130545NCT01130545, registered as of May 25, 2010.

Original languageEnglish
Article number177
JournalBMC Cardiovascular Disorders
Volume15
Issue number1
DOIs
StatePublished - 22 Dec 2015

Keywords

  • 3.0 Tesla
  • Gadofosveset trisodium
  • Gadolinium-based intravascular contrast agent
  • Image quality
  • MS-325
  • Navigator-based angiography
  • Respiratory motion correction
  • Whole-heart coronary magnetic resonance angiography

Fingerprint Dive into the research topics of 'Part 1 - Coronary angiography with gadofosveset trisodium: A prospective feasibility study evaluating injection techniques for steady-state imaging'. Together they form a unique fingerprint.

  • Cite this